What is it about?
Proceedings of the meeting focused on: "COVID-19 at the Intersection of Cancer, Immunity, and Immunotherapy". The Italian Network for Cancer Biotherapy meeting focused on the intricate relationship between COVID-19 and oncology. This intersection is particularly critical because cancer patients often exist in a state of compromised immunity, making them a unique demographic for studying both the virus's impact and the efficacy of the vaccines.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
Report of the Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting
Read the Original
This page is a summary of: Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020, Medical Oncology, January 2022, Springer Science + Business Media,
DOI: 10.1007/s00262-022-03145-0.
You can read the full text:
Resources
Contributors
The following have contributed to this page
